Isoray Tech Stack

Isoray uses 8 technology products and services including Google Font API, Vue.js, SweetAlert, and more. Explore Isoray's tech stack below.

  • Google Font API
    Font Scripts
  • Vue.js
    Javascript Frameworks
  • SweetAlert
    Javascript Libraries
  • ActiveCampaign
    Marketing Automation
  • Open Graph
    Miscellaneous
  • Prism
    Miscellaneous
  • Microsoft
    Miscellaneous
  • jQuery Mobile
    Mobile Frameworks

Media & News

Isoray's Email Address Formats

Isoray uses at least 4 format(s):
Isoray Email FormatsExamplePercentage
flast@isoray.comJDoe@isoray.com
95%
last@isoray.comDoe@isoray.com
2%
first@isoray.comJohn@isoray.com
1%
lfirst@isoray.comDJohn@isoray.com
2%

Frequently Asked Questions

Where is Isoray's headquarters located?

Minus sign iconPlus sign icon
Isoray's main headquarters is located at 350 Hills Street Suite 106 Richland, WA 99354 US. The company has employees across 4 continents, including North AmericaEuropeAsia.

What is Isoray's phone number?

Minus sign iconPlus sign icon
You can contact Isoray's main corporate office by phone at +1-509-375-1202. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Isoray's stock symbol?

Minus sign iconPlus sign icon
Isoray is a publicly traded company; the company's stock symbol is CATX.

What is Isoray's official website and social media links?

Minus sign iconPlus sign icon
Isoray's official website is isoray.com and has social profiles on LinkedIn.

How much revenue does Isoray generate?

Minus sign iconPlus sign icon
As of November 2023, Isoray's annual revenue reached $10M.

What is Isoray's SIC code NAICS code?

Minus sign iconPlus sign icon
Isoray's SIC code is 8711 - Engineering Services NAICS code is 325412 - Pharmaceutical Preparation Manufacturing.

How many employees does Isoray have currently?

Minus sign iconPlus sign icon
As of November 2023, Isoray has approximately 44 employees across 4 continents, including North AmericaEuropeAsia. Key team members include Chief Research And Development Officer: B. C.Chairman Of The Board: M. M.Coo: L. W.. Explore Isoray's employee directory with LeadIQ.

What industry does Isoray belong to?

Minus sign iconPlus sign icon
Isoray operates in the Medical Equipment Manufacturing industry.

What technology does Isoray use?

Minus sign iconPlus sign icon
Isoray's tech stack includes Google Font APIVue.jsSweetAlertActiveCampaignOpen GraphPrismMicrosoftjQuery Mobile.

What is Isoray's email format?

Minus sign iconPlus sign icon
Isoray's email format typically follows the pattern of flast@isoray.com. Find more Isoray email formats with LeadIQ.

How much funding has Isoray raised to date?

Minus sign iconPlus sign icon
As of November 2023, Isoray has raised $8M in funding. The last funding round occurred on Jul 11, 2018.

When was Isoray founded?

Minus sign iconPlus sign icon
Isoray was founded in 1998.
Isoray

Isoray

Medical Equipment ManufacturingWashington, United States11-50 Employees

The introduction of Cesium-131 represents the culmination of decades of work and millions of dollars of investment. Top medical centers, hospitals and clinics across the United States are now offering this breakthrough treatment for cancer patients.

The word brachytherapy derives from the Greek prefix brachy, meaning “short” or “close,” because the titanium capsules containing the radioisotope are implanted directly into the cancerous prostate gland.

Treatment of cancer using low dose radiation or “seed” brachytherapy was pioneered in the 1960’s as an effective alternative to radical prostatectomy. Pioneers in brachytherapy research initially theorized about the use of Cesium-131 in a titanium capsule, however scientific and economic limitations at the time prevented its development and Iodine-125 emerged as an alternative.

Beginning in 1967, Iodine-125 became the first radioisotope manufactured in a titanium capsule, or seed. While its use continues to this day, many patients and doctors in recent years have chosen Palladium-103, a faster-acting, shorter half-life isotope than Iodine-125. In order to obtain the clinical benefits of Palladium’s short half-life, patients and clinicians were forced to settle for lower energy or tissue penetrating power.

A team of scientists continued to believe the physical characteristics of Cesium-131* could potentially provide superior clinical benefits for seed brachytherapy patients. The team developed the patented process for economically separating and purifying Cesium-131 and in 1998 Isoray was founded to manufacture and commercialize Cesium-131 brachytherapy seeds to treat cancers.

Section iconCompany Overview

Headquarters
350 Hills Street Suite 106 Richland, WA 99354 US
Phone number
+1-509-375-1202
Website
isoray.com
SIC Code
8711 - Engineering Services
Stock Symbol
CATX
NAICS Code
325412 - Pharmaceutical Preparation Manufacturing
Founded
1998
Employees
11-50

Section iconFunding & Financials

  • $8M

    Isoray has raised a total of $8M of funding over 2 rounds. Their latest funding round was raised on Jul 11, 2018.

  • $10M$50M

    Isoray's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $8M

    Isoray has raised a total of $8M of funding over 2 rounds. Their latest funding round was raised on Jul 11, 2018.

  • $10M$50M

    Isoray's revenue is in the range of $10M$50M

© LeadIQ, Inc. All rights reserved.